BMS-986368
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for BMS-986368, covering 2024-05-13 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease [Phase 2]